Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/26/2025

Management of Ground Glass Opacities on Chest X-Ray

Initial Diagnostic Steps

  • Chest X-ray has poor sensitivity for detecting subtle ground glass changes and cannot reliably characterize the pattern or distribution of disease, according to the Journal of Microbiology, Immunology and Infection 2
  • Normal chest X-ray does not exclude significant pulmonary pathology, as abnormalities may not be visible early in disease course, as stated by the World Journal of Emergency Surgery 3
  • CT imaging is the imaging modality of choice for evaluating ground glass opacities, as it provides superior detail compared to chest radiographs, as noted by the Journal for ImmunoTherapy of Cancer 4

Systematic Diagnostic Approach

  • The American College of Chest Physicians recommends considering infectious etiologies, such as viral pneumonias, and evaluating for pulmonary edema or acute hypersensitivity pneumonitis in patients with acute presentation of ground glass opacities 5
  • Drug-induced pneumonitis should be considered in patients on molecular targeted agents or immune checkpoint inhibitors, as suggested by Chest 5

Management Based on CT Findings

  • If GGOs represent nondependent bilateral opacities involving ≤5% of a lung zone, the American Thoracic Society recommends performing follow-up chest CT in 2-3 years to monitor for progression 1
  • Part-solid nodules (GGO with solid component) require more aggressive evaluation than pure GGOs, and low-dose CT surveillance at 3, 12, and 24 months is recommended for part-solid nodules ≤8 mm, as stated by the Fleischner Society 1
  • For suspected drug-related pneumonitis, drug withdrawal is the mainstay of treatment, and grade 2 or higher pneumonitis requires oral/intravenous corticosteroids with minimum 4-6 week taper, as recommended by the Journal for ImmunoTherapy of Cancer 4

Multidisciplinary Evaluation

  • Pulmonology consultation is warranted for any patient with suspected pneumonitis, new pulmonary infiltrates, or unexplained GGOs, as recommended by the Journal for ImmunoTherapy of Cancer 4
  • Multidisciplinary discussion involving chest physician, radiologist, and pathologist is essential for accurate diagnosis, as suggested by Chest 5

Common Pitfalls to Avoid

  • Do not rely on chest X-ray alone for diagnosis or management decisions, as it lacks sensitivity for subtle ground glass changes, as stated by the Journal of Microbiology, Immunology and Infection and the World Journal of Emergency Surgery 2, 3
  • Avoid rapid steroid taper in drug-related pneumonitis, as recrudescence has been reported, and use minimum 4-6 week taper, as recommended by the Journal for ImmunoTherapy of Cancer 4